Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIMERIX LIMITED Regulatory Filings 2008

Dec 7, 2008

64804_rns_2008-12-07_0eb39a49-9dde-4486-91cd-fafaf3010553.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [141 x 12] intentionally omitted <==

==> picture [141 x 11] intentionally omitted <==

==> picture [141 x 12] intentionally omitted <==

PRESS ANNOUNCEMENT

==> picture [141 x 12] intentionally omitted <==

==> picture [141 x 11] intentionally omitted <==

1001 Lower Landing Road, Blackwood, NJ 08012 P 856-401-1080 F 856-401-1090 fax www.sunbiomed.com

Contact: Jack Kerins, CEO, Sun Biomedical Laboratories, Inc. Telephone: (856) 401-1080 Email: [email protected]

2009 Confidence Prize - “Zloty Otis” (“Gold Otis”) Award

Blackwood, NJ, December 2008—Sun Biomedical Laboratories, Inc.’s (SBL) OraLine 4 saliva drug screen has been nominated for Poland’s 2009 Confidence Prize, known as “Zloty Otis” (“Gold Otis”).

First presented in 2004, the “Zloty Otis” is awarded annually by consumers of the Polish pharmaceutical market, indicating products in which they feel personal trust – thus the award’s name, Confidence Prize.

Administrators of the award set a goal that it fulfills three functions: education, social and consumer-related.

Sun Biomedical is extremely proud of being nominated for this award and would like to extend our appreciation to our distribution partner in Poland, TOP-MED, for helping to make this possible.

About Sun Biomedical Laboratories, Inc.

Sun Biomedical Laboratories, Inc. produces both urine and saliva based drugs of abuse testing devices at its main facility in Blackwood, New Jersey. The company has established an industry benchmark with the most sensitive saliva drugs of abuse testing device available on the market today. The company also has a portfolio of research into the use of saliva as a diagnostic medium for other disease states that provide the foundation for continued research and development and a broader portfolio of point of care testing devices. The Company, founded in 1993, is an operating unit of Sun Biomedical Limited, a public company listed on the Australian Stock Exchange (ASX) under the symbol "SBN". For more information about Sun Biomedical Laboratories and its products, contact us at 888-440-8388 or visit www.sunbiomed.com.